PAR
Click for more information
1.69% 29.0¢ paradigm biopharmaceuticals limited..

Ann: Paradigm provides MPS Clinical Program update, page-9

  1. vaxjopies
    360 Posts.
    lightbulb Created with Sketch. 42
    clock Created with Sketch.
    08/08/22
    10:12
    Post #: 62978473
    it also solidifies PAR as not a one trick pony with just OA, that there is now real potential for 2-3 clinical pathways to commercialisation for iPPS and this just adds more value
    PAR Price at posting: $1.86 Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 12  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

MCT Metalicity looking for offers on Admiral Bay zinc project
right-arrow Created with Sketch.
AGY Argosy signs deal to sell battery-grade Rincon lithium to Korea
right-arrow Created with Sketch.
LKE Lake Resources implies news article on job cuts made up; non-core sales "not material" and no rule 15.7 breach
right-arrow Created with Sketch.
NRX Noronex joins forces with South32 to look for copper in Namibia
right-arrow Created with Sketch.
IMR Imricor raises $35M to pursue growth and expansion into Australia and NZ
right-arrow Created with Sketch.
NEWS Talking Australia's very competitive property landscape: Realty Talks
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
29.0¢ 		Change
-0.005(1.69%) 		Mkt cap ! $101.4M
Open High Low Value Volume
29.5¢ 30.0¢ 29.0¢ $40.16K 137.1K

Buyers (Bids)

No. Vol. Price($)
5 66491 29.0¢
 

Sellers (Offers)

Price($) Vol. No.
29.5¢ 33118 1
View Market Depth
Last trade - 16.10pm 23/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.